How Tirzepatide Works Tirzepatide's dual agonism creates synergistic metabolic effects: GIP receptor activation enhances insulin secretion and may improve fat metabolism GLP-1 receptor activation suppresses glucagon, slows gastric emptying, and reduces appetite Combined pathway stimulation produces greater metabolic benefits than single-pathway agonists Dose-dependent effects allow for personalized titration based on individual response The dual mechanism explains why tirzepatide has demonstrated superior weight loss outcomes compared to single GLP-1 agonists in head-to-head clinical trials
COA & Testing (30%) We check that COAs are from recognized third-party labs, recent (6 months), verifiable on the lab's website, and critically for GHK-Cu confirm copper chelation, not just the peptide sequence
Keep out of reach of children
Clinical research on using AHK-Cu and GHK-Cu together for hair growth is still developing
updated and replaced by NG246) NICE
For patients losing significant weight on compounded semaglutide or tirzepatide, topical GHK-Cu is sometimes used to support skin elasticity, though specific evidence in this population is limited